Active Not Recruiting OBSERVATIONAL NCT07224347

Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT)

Sponsor: Anne Murray

Conditions Bleeding Cancer Dementia Depression Frailty Functional Disability Heart Disease Stroke

Updated 1 time since 2025 Last updated: Oct 31, 2025 Started: Jul 15, 2019 Primary completion: Apr 30, 2026 Completion: Apr 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07224347, this observational or N/A phase trial focuses on Bleeding and Cancer and remains ongoing. Sponsored by Anne Murray, it has been updated 1 time since 2019, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

1 version recorded

Active Not Recruiting [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Anne Murray
Bayer
Berman Center for Outcomes and Clinical Research
Monash University
National Cancer Institute (NCI)
National Health and Medical Research Council, Australia
National Institute on Aging (NIA)

Data source: Hennepin Healthcare Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Adelaide, Australia , Ann Arbor, United States , Atlanta, United States , Baton Rouge, United States , Bendigo, Australia , Birmingham, United States , Burnie, Australia , Chicago, United States , Dallas, United States , Detroit, United States and 25 more locations